Furthermore, given the observed immune‐enhancing effect, CNOT7 depletion could represent an effective adjuvant therapy in immunotherapy for HCC to prevent microbial infections and inflammation‐associated disease. This evidence concerns the gene CNOT7 and glycogen storage disease VI.